The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, ...

The following is a summary of "Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure ...

GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.